Recent News


February 3-5, 2015: InformEx 2015
PCAS-Nanosyn with be at Informex 2015 in New Orleans, LA. The 2015 Conference will cover a diverse range of emerging issues and trends relevant to the chemical industry including, an economic overview & state of the custom manufacturing industry. InformEx will again host programs focused on specific product areas throughout the show floor.

March 16-19, 2015: DCAT Week '15
PCAS-Nanosyn with be DCAT Week '15 in New York, NY. DCAT Week is one of the largest gatherings in the world for the pharmaceutical and related industries. Its unique model brings together a variety of industry CEOs, presidents, business development, sales, marketing, supply management, and more from around the globe for high-level meetings, strategy sessions, education programs, and networking events.

Please contact James Faust (jfaust@pcasamerica.com) to schedule a meeting at any of these events or to discover how PCAS-Nanosyn can bridge the gap between Discovery and Commercialization.

Drug Discovery to Commercialization

PCAS-Nanosyn is designed to bridge the capabilities of the two parent companies and offer a seamless transition to pharmaceutical and biotech customers for custom chemical services from discovery chemistry and biology at Nanosyn through to commercial scale API and fine chemical production at PCAS. The excellent quality systems and kilolab scale capabilities of the JV are also a great fit to serve the scale-up and commercial needs for other business segments, such as medical devices, diagnostics, and semi-conductors.

The primary site of the JV is a R&D and cGMP kilolab in Santa Rosa, CA, north of San Francisco in the heart of Sonoma County wine country, that has a 30-year experience base as a FDA registered facility. With six, separate cGMP suites with walk-in hoods, including two, certified Class 10,000 clean rooms, coupled with R&D and analytical testing capabilities that have recently undergone significant upgrades, the site combines small company personal service and flexibility with large company derived expertise for process identification, development, scale-up, analytical methods development and testing, and manufacture under cGMP protocols.